CDC5L and central nervous system cancer: Studies indicated that CDC5L expression in glioma and hepatocellular carcinoma was increased, and CDC5L interference could increase the cell cycle arrest in G2 phase and inhibit the proliferation of glioma cells and hepatoma cells [15, 16].